Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart  by Schachner, Thomas et al.
M
a
T
G
Cardiopulmonary Support and Physiology Schachner et al
1
CSPyocardial enzyme release in totally endoscopic coronary
rtery bypass grafting on the arrested heart
homas Schachner, MD,a Nikolaos Bonaros, MD,a Elisabeth Ruetzler, MD,a Felix Weidinger,a Armin Oehlinger, MD,auenther Laufer, MD,a Guy Friedrich, MD, FESC,b and Johannes Bonatti, MD, FECTSa
O
a
m
t
l
M
3
a
t
i
7
i
t
i
g
d
1
(
R
t
s
d
p
P
e
c
(
s
k
e
e
C
e
m
s
v
MFrom the Departments of Cardiac Surgerya
and Cardiology,b Innsbruck Medical Uni-
versity, Innsbruck, Austria.
Dr Johannes Bonatti received grant support
and lecture fees from Intuitive Surgical.
Received for publication Jan 20, 2007; re-
visions received March 3, 2007; accepted
for publication May 2, 2007.
Address for reprints: Thomas Schachner,
MD, Department of Cardiac Surgery, Med-
ical University Innsbruck, Anichstrasse 35,
6020 Innsbruck, Austria (E-mail: Thomas.
Schachner@i-med.ac.at).
J Thorac Cardiovasc Surg 2007;134:1006-11
0022-5223/$32.00
Copyright © 2007 by The American Asso-
ciation for Thoracic Surgerye
doi:10.1016/j.jtcvs.2007.05.035
006 The Journal of Thoracic and Cardbjective: Robotic totally endoscopic coronary artery bypass grafting enables coronary
rtery bypass grafting without sternotomy or thoracotomy. However, longer cardiopul-
onary bypass and aortic endo-occlusion times are currently required compared with
hose of standard coronary artery bypass grafting operations. We investigated whether
onger operation times affect the myocardial enzyme release and the postoperative course.
ethods: From 2001 through 2006, 85 patients with a median age of 58 years (range,
1–76 years) underwent totally endoscopic coronary artery bypass grafting on the
rrested heart by using the da Vinci telemanipulator and remote access perfusion
hrough the femoral vessels (Estech or Heartport). The operations involved the left
nternal thoracic artery–left anterior descending coronary artery or diagonal branch (n
4); right internal thoracic artery–right coronary artery (n  2); double-vessel left
nternal thoracic artery–obtuse marginal branch/circumflex artery and right internal
horacic artery–left anterior descending coronary artery (n  8); and double-vessel left
nternal thoracic artery–left anterior descending coronary artery and saphenous vein
raft–right coronary artery (n  1). Totally endoscopic coronary artery bypass grafting
uration was 254 minutes (range, 178–710 minutes), cardiopulmonary bypass time was
14 minutes (range, 57–428 minutes), and aortic endo-occlusion time was 65 minutes
range, 28–230 minutes).
esults: The postoperative ventilation time was 8 hours (range, 0–278 hours), and
he intensive care unit stay was 20 hours (range, 11–389 hours). The postoperative
tay at our department was 6 days (range, 4–22 days), and we observed no hospital
eaths in this series. Forty-five percent of the patients had an increased postoperative
eak creatine kinase MB level, and 75% had an increased troponin T level.
ostoperative peak creatine kinase MB levels significantly increased with totally
ndoscopic coronary artery bypass grafting duration (r  0.588, P  .001),
ardiopulmonary bypass time (r 0.521, P .001), and aortic endo-occlusion time
r  0.400, P  .001) and translated into moderately prolonged intensive care unit
tay (r  0.432, P  .001) and ventilation time (r  0.517, P  .001). Creatine
inase MB levels were not associated with sex, age, or EuroSCORE. The postop-
rative left ventricular ejection fraction did not differ significantly from the preop-
rative left ventricular ejection fraction.
onclusions: Myocardial protection can be established in arrested heart totally
ndoscopic coronary artery bypass grafting operations. An influence of increased
yocardial enzyme release on postoperative ventilation time and intensive care unit
tay is detectable but does not translate into an early mortality or a decrease in left
entricular ejection fraction.
yocardial enzyme release after standard coronary artery bypass grafting
(CABG) occurs frequently and has been documented, especially for
creatine kinase MB (CK-MB), troponin T, and troponin I.1-3 Totallyndoscopic CABG (TECAB) is an evolving technology and is meanwhile an
iovascular Surgery ● October 2007
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Pstablished procedure at our department of cardiac sur-
ery.4-8 The advantage of TECAB is the avoidance of
ternotomy or thoracotomy. Furthermore, hybrid revas-
ularization concepts with endoscopic internal thoracic
rtery grafting and percutaneous coronary intervention
an be realized.9,10 Earlier resumption of daily activities,
uch as housework, driving a car, or biking, has been
emonstrated for TECAB operations compared with re-
ults from sternotomy operations.11
Our procedure of choice for arrested-heart TECAB
AHTECAB) is to use femoral access cardiopulmonary
ypass (CPB) with balloon endo-occlusion of the ascending
orta and intermittent antegrade cardioplegia. CPB times
nd aortic endo-occlusion times (ie, myocardial ischemic
imes) are longer compared with those of conventional
ABG techniques. Hence, we aimed to quantify myocar-
ial enzyme release and to compare results with historical
alues of standard CABG operations from the literature.
urthermore, we wanted to find preoperative, operative,
nd postoperative factors that are associated with an
ncreased myocardial enzyme release. Finally, we inves-
igated whether the myocardial enzyme release impaired
yocardial contractility.
aterials and Methods
he institutional review board approved the TECAB operations,
nd informed consent was obtained from all patients.
urgical Technique
ighty-five patients (EuroSCORE 1 [range, 0-5]) were intended to
ndergo AHTECAB with the da Vinci telemanipulator (Intuitive,
nc) through 3 left-sided (right-sided in 2 right internal thoracic
rtery [RITA]-right coronary artery [RCA] grafts) thoracic ports
1 camera port in the fifth and 2 working ports in the third and
eventh intercostal spaces). Femoral access CPB was established
ith balloon endo-occlusion of the aorta for cardiac arrest, fol-
Abbreviations and Acronyms
AHTECAB arrested-heart totally endoscopic
coronary artery bypass grafting
CABG  coronary artery bypass grafting
CK-MB  creatine kinase MB
CPB  cardiopulmonary bypass
ICU  intensive care unit
LAD  left anterior descending coronary artery
LITA  left internal thoracic artery
LVEF  left ventricular ejection fraction
RCA  right coronary artery
RITA  right internal thoracic artery
TECAB  totally endoscopic coronary artery
bypass graftingowed by antegrade cardioplegia (ESTECH from ESTECH, (
The Journal of Thoracicnc; Heartport from Heartport, Inc), as described in previous
ublications.5-7
Patient demographics are listed in Table 1.
The operations performed were left internal thoracic artery
LITA)–left anterior descending coronary artery (LAD) or Dg
n  74); RITA-RCA (n  2); double-vessel LITA–OM/circum-
ex artery and RITA-LAD (n  8); and double vessel LITA-LAD
nd saphenous vein graft–RCA (n  1). Two LITA-LAD and
aphenous vein graft–marginal branch CABGs were performed
hrough a sternotomy after conversion was necessary. In a total of
5 intended AHTECABs, 13 (15.3%) conversions were necessary
n  1 minithoracotomy and n  12 sternotomies). In the second
alf of the series, the conversion rate decreased to 4 (9.3%) of 43.
The TECAB duration was 254 minutes (178–710 minutes),
PB time was 114 minutes (57–428 minutes), and aortic endo-
cclusion time was 65 minutes (28–230 minutes).
Postoperatively, the myocardial enzymes were measured at the
ime the patient arrived at the intensive care unit (ICU), as well as
hours, 8 to 12 hours, and 32 to 36 hours postoperatively.
Postoperative peak levels of absolute CK-MB could be ob-
ained from 77 of 85 patients. Postoperative peak levels of troponin
were obtained from 47 of 85 patients because troponin T levels
ere measured only during the second two thirds of the study.
tatistical Analysis
tatistical analysis was carried out with SPSS 12.0 software
SPSS, Inc). Continuous variables are given as medians
minimum-maximum). Categoric variables are given as per-
entages. The Pearson correlation coefficient (r) was calculated
or continuous variables. The Mann–Whitney U test was ap-
lied for comparisons of enzyme levels with categoric factors.
he Wilcoxon test for paired samples was used to compare
reoperative and postoperative left ventricular ejection fraction
able 1. Patient demographics of 85 patients in whom
HTECAB was intended
ariable
Median (range) or
percentage
ale sex 78%
ge (y) 58 (31–76)
reoperative serum creatinine 1.2 mg/dL 12%
istory of smoking 35%
iabetes mellitus 12%
ypercholesterolemia 68%
ypertriglyceridemia 17%
rterial hypertension 79%
hronic obstructive pulmonary disease 15%
eripheral vascular disease 2%
istory of myocardial infarction 28%
istory of percutaneous coronary intervention 37%
istory of stroke 1%
arotid artery stenosis 2%
HTECAB, Arrested-heart totally endoscopic coronary artery bypass
rafting.LVEF).
and Cardiovascular Surgery ● Volume 134, Number 4 1007
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CSPesults
n our series, 45% of the patients had increased peak
K-MB levels greater than the locally used cutoff of 25 U/L
Figure 1). The median postoperative peak CK-MB level
as 23 U/L (range, 7–883 U/L). Seventy-five percent of the
atients had increased peak troponin T levels of greater than
he locally used cutoff of 0.039 g/L. The median postop-
rative peak troponin T level was 0.088 g/L (0.01-6.17
g/L). Postoperative troponin T and CK-MB levels showed
high correlation (P  .001, r  0.974).
Myocardial infarction, confirmed by means of electro-
ardiographic changes, was found in 2 (2.4%) patients. The
rst patient underwent TECAB without conversion and
howed a postoperative peak CK-MB level of 137 U/L. An
ntraoperative occlusion of the posterolateral artery oc-
urred, which was treated with immediate percutaneous
oronary angioplasty and stent placement. The preoperative
VEF of this patient was 53%, and the postoperative LVEF
as 54%. In the second patient a double-vessel TECAB was
ntended, but conversion was required, and the patient
howed a postoperative peak CK-MB level of 883 U/L. The
eason for the myocardial ischemia was a stenosis of a
arginal branch, which had been underestimated in signif-
igure 1. Postoperative peak levels of creatine kinase MB (CK-MB)
f 85 patients who underwent totally endoscopic coronary artery
ypass grafting on the arrested heart by using femoral access
ardiopulmonary bypass and aortic endo-occlusion. The CK-MB
evels were divided into 4 groups: normal CK-MB, less than 25 U/L;
- to 3-fold, greater than 25 to 75 U/L; 3- to 5-fold, greater than 75 to
25 U/L; and greater than 5-fold, greater than 125 U/L increased
K-MB levels.cance preoperatively and required additional bypass graft- s
008 The Journal of Thoracic and Cardiovascular Surgery ● Octng through a sternotomy. The preoperative LVEF of this
atient was 62%, and the postoperative LVEF was 52%.
An increased CPB time was associated with an increased
ostoperative peak CK-MB level (P  .001, r  0.521;
igure 2). An increased aortic endo-occlusion time was
ssociated with an increased postoperative peak CK-MB
evel as well (P  .001, r  0.400; Figure 3).
The postoperative ventilation time was 8 hours (range,
-278 hours). The postoperative peak CK-MB levels were
ositively correlated to the postoperative ventilation time
P  .001, r  0.517; Figure 4).
The postoperative length of stay at the ICU was 20 hours
range, 11–389 hours). Increased postoperative peak
K-MB levels were associated with an increased postoper-
tive ICU stay (P  .001, r  0.432; Figure 5).
The postoperative length of stay at our department of
ardiac surgery was 6 days (range, 4–22 days). Increased
ostoperative peak CK-MB levels were associated with an
ncreased postoperative length of stay (P .015, r 0.279;
igure 6).
The CK-MB levels were not associated with sex, age,
uroSCORE, preoperative serum creatinine levels of 1.2
g/dL or more, history of smoking, diabetes mellitus, hy-
ercholesterolemia, hypertriglyceridemia, arterial hyperten-
igure 2. Association of cardiopulmonary bypass time and post-
perative peak creatine kinase (CK-MB) level in patients who
nderwent totally endoscopic coronary artery bypass grafting on
he arrested heart by using femoral access cardiopulmonary
ypass and aortic endo-occlusion.ion, chronic obstructive pulmonary disease, peripheral vas-
ober 2007
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Pular disease, history of myocardial infarction, history of
ercutaneous coronary intervention, history of stroke, or
arotid artery stenosis.
Conversion to minithoracotomy or sternotomy increased
PB time to 256 minutes (range, 83–428 minutes) com-
ared with 100 minutes (range, 57–273 minutes) in uncon-
erted patients (P  .001). Conversion also increased aortic
ndo-occlusion time to 153 minutes (range, 37–230 min-
tes) compared with 63 minutes (range, 28–172 minutes) in
nconverted patients (P  .005). The peak CK-MB level of
onverted patients was 33 U/L (range, 18–883 U/L) versus
3 U/L (range, 7–137 U/L) in unconverted patients.
Similar to CK-MB levels, the postoperative peak tropo-
in T levels were associated with CPB time (P  .001, r 
.657), aortic endo-occlusion time (P  .001, r  0.543),
ostoperative ventilation time (P  .001, r  0.506), post-
perative length of stay at the ICU (P  .002, r  0.446),
nd postoperative length of stay at our department of car-
iac surgery (P  .029, r  0.322). The postoperative peak
roponin T levels were not significantly associated with sex,
ge, EuroSCORE, preoperative serum creatinine levels of
.2 mg/dL or more, history of smoking, diabetes mellitus,
ypercholesterolemia, hypertriglyceridemia, arterial hyper-
ension, chronic obstructive pulmonary disease, peripheral
ascular disease, history of myocardial infarction, history of
igure 3. Association of aortic endo-occlusion time and postop-
rative peak creatine kinase MB (CK-MB) levels in patients who
nderwent totally endoscopic coronary artery bypass grafting on
he arrested heart with femoral access cardiopulmonary bypass.ercutaneous coronary intervention, history of stroke, or c
The Journal of Thoracicarotid artery stenosis. The peak troponin T level of con-
erted patients was 0.751 g/L (range, 0.104–6.170 g/L)
ersus 0.07 g/L (range, 0.001–0.322 g/L) in unconverted
atients (P  .002).
The postoperative LVEF could be obtained from 51
atients (by means of echocardiography or left-sided
eart catheterization). The postoperative LVEF was
2% (range, 35%–75%) and did not differ significantly
rom preoperative values of 62% (range, 40%– 86%; Fig-
re 7).
There was no hospital death observed in this series.
iscussion
HTECAB enables performing coronary surgery without
ternotomy or thoracotomy. However, longer operative
imes need to be accepted to achieve this goal. In addition,
sophisticated femoral access perfusion system with bal-
oon-carrying tips for aortic endo-occlusion and cardiople-
ic arrest is necessary. We found myocardial enzyme re-
eases (CK-MB and troponin T) that are well comparable
ith those of standard CABG techniques.1,2 Costa and
olleagues1 describe a postoperative abnormal CK-MB
evel increase in 61.9% of patients undergoing CABG in
he Arterial Revascularization Therapies Study trial. By
igure 4. Association between postoperative peak levels of cre-
tine kinase MB (CK-MB) and the postoperative ventilation time
f patients who underwent totally endoscopic coronary artery
ypass grafting on the arrested heart with femoral access car-
iopulmonary bypass and aortic endo-occlusion.omparison, in our series only 45% of the patients had
and Cardiovascular Surgery ● Volume 134, Number 4 1009
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CSPncreased (peak) CK-MB levels of greater than the lo-
ally used cutoff of 25 U/L. In 7.5% of standard, on-
ump 1- to 2-vessel revascularizations, Gerola and asso-
iates12 found a postoperative myocardial infarction
efined as a 5-fold (or more) increase of CK-MB levels.
n our study 2.6% of the patients had peak CK-MB levels
hat reached greater than 5-fold of normal values. Thus,
ith our technique of AHTECAB, we can provide myo-
ardial protection that meets the standards of current
rrested-heart CABG through a sternotomy or that might
ven be better. Further direct comparison studies are
ecessary, however, to prove this.
We found a very reasonable association for aortic endo-
cclusion time, which means myocardial ischemic time and
eak CK-MB levels. The same correlation was found for
PB time and postoperative peak CK-MB levels. An inter-
sting question was whether increased CK-MB levels trans-
ate into a longer postoperative ICU stay. Indeed, we found
onger ventilation times and longer ICU stays to be associ-
ted with higher myocardial enzyme release. The increased
K-MB levels were even associated with a longer postop-
rative stay at our department. However, it has to be taken
nto consideration that this regression line was inclining
ery slowly, and after 6 days, the patients were generally
igure 5. Association between postoperative peak levels of
reatine kinase MB (CK-MB) and the postoperative length of
tay at the intensive care unit (ICU) of patients who underwent
otally endoscopic coronary artery bypass grafting on the
rrested heart with femoral access cardiopulmonary bypass
nd aortic endo-occlusion.ischarged home. L
010 The Journal of Thoracic and Cardiovascular Surgery ● OctWe are aware that longer CPB times and aortic cross-
lamp times are necessary in TECAB compared with stan-
ard CABG. We regard this as the payoff necessary to avoid
ternotomy or thoracotomy. In 15% of the patients, how-
ver, a conversion to a larger incision was necessary; in the
econd half of this series, the conversion rate decreased to
ess than 10%. The conversion increased both CPB time and
ortic endo-occlusion time and resulted in a significantly
ncreased postoperative peak troponin T level but a nonsig-
ificant increase in CK-MB level.
The most important question was of course the effect
n clinical outcome and myocardial pump function. A
ero hospital mortality in this series demonstrates the
afe conduct of this demanding procedure. The absence
f a loss of LVEF shows that the myocardial contractile
unction is preserved, despite postoperative myocardial
nzyme releases. Furthermore, most of the patients in our
eries had normal preoperative LVEF values (with a
edian preoperative LVEF of 63%). Thus an increase of
VEF postoperatively could not be expected.
We conclude that myocardial protection can be
chieved in AHTECAB operations. An influence of in-
reased myocardial enzyme release on postoperative ven-
ilation time and ICU stay is detectable. This, however,
oes not translate into early mortality or a decrease in
igure 6. Association between postoperative peak levels of cre-
tine kinase MB (CK-MB) and the postoperative length of stay at
ur department of patients who underwent totally endoscopic
oronary artery bypass grafting on the arrested heart with fem-
ral access cardiopulmonary bypass and aortic endo-occlusion.VEF.
ober 2007
R1
1
1
F
l
w
a
a
Schachner et al Cardiopulmonary Support and Physiologyeferences
1. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lin-
denboom W, et al. Incidence, predictors, and significance of abnormal
cardiac enzyme rise in patients treated with bypass surgery in the
Arterial Revascularization Therapies Study (ARTS). Circula-
igure 7. Comparison between preoperative and postoperative
eft ventricular ejection fraction (LVEF) in patients who under-
ent totally endoscopic coronary artery bypass grafting on the
rrested heart with femoral access cardiopulmonary bypass and
ortic endo-occlusion. n.s., not significant.tion. 2001;104:2689-93.
The Journal of Thoracic2. Fransen EJ, Diris JH, Maessen JG, Hermens WT, van Dieijen-
Visser MP. Evaluation of “new” cardiac markers for ruling out
myocardial infarction after coronary artery bypass grafting. Chest.
2002;122:1316-21.
3. Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G,
et al. Relationship between postoperative cardiac troponin I
levels and outcome of cardiac surgery circulation. 2006;114:
1468-75.
4. Bonatti J, Schachner T, Bernecker O, Chevtchik O, Bonaros N, Ott H,
et al. Robotic totally endoscopic coronary artery bypass: program
development and learning curve issues. J Thorac Cardiovasc Surg.
2004;127:504-10.
5. Bonatti J, Schachner T, Bonaros N, Oehlinger A, Danzmayr M,
Rutzler E, et al. Ongoing Procedure development in robotically as-
sisted totally endoscopic coronary artery bypass grafting (TECAB).
Heart Surg Forum. 2005;8:E287-91.
6. Schachner T, Bonaros N, Feuchtner G, Muller L, Laufer G, Bonatti J.
How to handle remote access perfusion for endoscopic cardiac sur-
gery. Heart Surg Forum. 2005;8:E232-5.
7. Bonatti J, Schachner T, Bonaros N, Oehlinger A, Danzmayr M,
Jonetzko P, et al. Technical challenges in totally endoscopic robotic
coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2006;131:
146-53.
8. Schachner T, Bonaros N, Laufer G, Bonatti J. The Estech remote
access perfusion cannula in minimally invasive cardiac surgery. Heart
Surg Forum. 2004;7:E632-5.
9. Friedrich GJ, Jonetzko P, Bonaros N, Schachner T, Danzmayr M,
Bonatti J, et al. Hybrid coronary artery revascularization: logistics and
program development. Heart Surg Forum. 2005;8:E258-61.
0. Bonatti J, Schachner T, Bonaros N, Laufer G, Kolbitsch C, Margreiter
J, et al. Robotic totally endoscopic coronary artery bypass and catheter
based coronary intervention in one operative session. Ann Thorac
Surg. 2005;79:2138-41.
1. Bonaros N, Schachner T, Ohlinger A, Friedrich G, Laufer G, Bonatti
J. Assessment of health-related quality of life after coronary revascu-
larization. Heart Surg Forum. 2005;8:E380-5.
2. Gerola LR, Buffolo E, Jasbik W, Botelho B, Bosco J, Brasil L, et al.
Off-pump versus on-pump myocardial revascularization in low-risk
patients with one or two vessel disease: perioperative results in a
multicenter randomized controlled trial. Ann Thorac Surg. 2004;77:
569-73.
and Cardiovascular Surgery ● Volume 134, Number 4 1011
CS
P
